BRIDGEBIO PHARMA INC - NOTE 2.500% 3/1

Historical Portfolio Holders from Q1 2021 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Debt / NOTE 2.500% 3/1
Principal, excl. options Q1 2024
541 M
Holdings value Q1 2024
$582 M
Value change Q1 2024
-$102 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
39
Number of buys Q1 2024
14
Number of sells Q1 2024
-19
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
-0.001%
CUSIP
10806XAB8
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q1 $541 M $582 M -$102 M $1.08 39
2023 Q4 $525 M $636 M +$21.4 M $1.21 41
2023 Q3 $513 M $501 M +$21.5 M $0.96 39
2023 Q2 $509 M $408 M -$33.1 M $0.78 34
2023 Q1 $537 M $417 M +$6.94 M $0.74 35
2022 Q4 $533 M $244 M +$73.2 K $0.45 31
2022 Q3 $391 M $235 M -$522 K $0.59 31
2022 Q2 $389 M $215 M -$83.8 M $0.55 32
2022 Q1 $529 M $319 M -$9.34 M $0.59 34
2021 Q4 $520 M $390 M -$23.3 M $0.73 37
2021 Q3 $533 M $746 M -$33.8 M $1.38 42
2021 Q2 $554 M $913 M +$82.2 M $1.64 37
2021 Q1 $509 M $842 M +$842 M $1.65 34